The American Diabetes Association (ADA) has blocked the publication of a planned editorial and seven opinion articles in its flagship journal Diabetes Care that would have addressed the controversial removal of the journal’s editor-in-chief from the association’s annual meeting in June, according to new reporting from Ars Technica published July 17.
The development represents a second act of editorial suppression in a controversy that has already drawn widespread condemnation from the scientific community.
What Happened in June
On June 5, at the ADA’s 86th Scientific Sessions in New Orleans, Dr. Steven E. Kahn, editor-in-chief of Diabetes Care, was escorted out of the conference hall by police. He and four other researchers were handing out reprints of a peer-reviewed editorial that had been published in the journal just weeks earlier. The editorial, titled “Misguided Brushes of a Pen Continue to Dismantle and Destroy Biomedical Research in the United States,” criticized the Trump administration’s cuts to NIH funding and a proposed rule giving political appointees final authority over federal grant decisions.
The ADA initially cited a violation of the conference’s code of conduct, then said the researchers were violating IRS rules requiring a nonpartisan environment at 501(c)(3) organizational events. Video evidence shows the researchers distributing materials calmly, without disruption.
The ouster triggered a wave of resignations, including ADA President-Elect Jennifer Green and Scientific Sessions Planning Committee Chair Mark Atkinson. ADA CEO Chuck Henderson issued a video apology on June 10, announcing an independent review. Hundreds of attendees walked out of the presidential plenary in solidarity.
The New Details
The July 17 Ars Technica article, by Jennifer Ouellette, reveals that the editors of Diabetes Care had scheduled a collection of one editorial and seven opinion articles for publication on July 13, pieces that would have directly addressed both the June 5 incident and the broader threat to scientific editorial independence.
The articles were provided in advance to ADA leadership, along with an offer to publish the association’s own response simultaneously. The ADA refused to publish the articles.
In response, the editors posted the entire collection as a preprint on Zenodo (DOI: 10.5281/zenodo.21300053), under the title “Community Voices: On the Events of the American Diabetes Association 86th Scientific Sessions.” The preprint includes contributions from Kahn, Anderson, Buse, Selvin, Gannon, Kelly, Ryder, Schatz, Atkinson, Hirsch, Nathan, and Limbaugh.
“The ADA has already tried to restrict editorial freedom once before,” the editors wrote. The association has offered no public explanation for blocking the follow-up publications.
Why It Matters
The case has become a flashpoint for the tension between scientific societies and political pressure. The ADA simultaneously hosted Richard Woychik, a senior advisor to the NIH Director for the “Make America Healthy Again” strategy, as a keynote speaker, a politically appointed figure whose presence undercuts the argument that the conference needed to be strictly nonpartisan.
BMJ Editor-in-Chief Kamran Abbasi warned in a June 19 editorial that medical societies that “compromise editorial independence do so at their peril.” The incident has drawn comparisons to other recent cases where journal editors have faced pressure over content deemed politically sensitive.
The longer-term damage may be institutional. Diabetes Care has an impact factor of 22.6, the sixth highest in endocrinology and metabolism. If the ADA’s relationship with its own editorial leadership is seen as compromised, the journal’s standing, and the association’s credibility, could suffer.
Sources
1. J. Ouellette, “Troubling new details emerge on diabetes journal ouster controversy,” Ars Technica, July 17, 2026. https://arstechnica.com/science/2026/07/troubling-new-details-emerge-on-diabetes-ouster-controversy/
2. S.E. Kahn et al., “Community Voices: On the Events of the American Diabetes Association 86th Scientific Sessions,” Zenodo (2026). DOI: 10.5281/zenodo.21300053
3. S.E. Kahn, C.A.M. Anderson, J.B. Buse, E. Selvin, “Misguided Brushes of a Pen Continue to Dismantle and Destroy Biomedical Research in the United States,” Diabetes Care (2026). DOI: 10.2337/dci26-0068
4. E. Cooney, “Fresh turmoil roils American Diabetes Association following controversy at conference,” STAT News, July 16, 2026.